D

DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE (Private limited company)

DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE
BE 0836.671.322 Active ●Place du Nouveau Marché aux Grains 13, 1000 Bruxelles

DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0836.671.322. It was founded on 31-05-2011. Its registered office is in Brussels. Its main activity is: Human health activities. Its annual accounts for 2024 report equity of € 659 800 and a profit of € 119 664. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). Its annual accounts for the 2025 financial year have not been filed, although the legal deadline has passed.

Information last updated on 21-10-2026.

Company information

Status
Active
Enterprise number
BE 0836.671.322
VAT registered
No
Founded
31-05-2011
Latest accounts
2024
Employees
-
Region
Brussels-Capital
Establishments
2
Filing record
2025 accounts not filed
Peppol e-invoicing
Registered
Registered office
Place du Nouveau Marché aux Grains 13, 1000 Bruxelles
Main activity
Human health activities
NACE activities
86210 Activités de médecine générale

Key figures of DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE

2024202320222021
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ 119 664+2 %€ 117 062-1 %€ 118 709-25 %€ 158 071
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 659 800+3 %€ 640 9690 %€ 638 867+4 %€ 613 226
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 1 135 957-6 %€ 1 204 936+1 %€ 1 191 584+4 %€ 1 145 144
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ 355 557-4 %€ 369 308+21 %€ 305 660-11 %€ 344 863
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Brussels.

CompanyTown
COHEZIO 1000 Bruxelles
Liantis service externe pour la prévention et la protection 1000 Bruxelles
Haemek BE Holding 1000 Bruxelles
VERANNEMAN 1000 Bruxelles
Clinique dentaire des Arts 1000 Bruxelles
ORTHOCLINIC 1000 Bruxelles
GESTION DE CABINETS MEDICAUX 1000 Bruxelles
NEURO SAINT - JEAN 1000 Bruxelles
Looking for more information about DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE still active? Yes. The Crossroads Bank for Enterprises lists DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE as active.

What is the VAT number of DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE? DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE is not registered for VAT. Its enterprise number is 0836.671.322.

When was DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE founded? DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE was founded on 31-05-2011.

What is the address of DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE? The current registered office of DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE is Place du Nouveau Marché aux Grains 13, 1000 Bruxelles.

When did DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE last file annual accounts? The latest annual accounts of DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE were filed on 31-10-2025.

Does DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE file its annual accounts on time? The annual accounts of DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE for the 2025 financial year have not been filed, although the legal deadline has passed.

Is DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE financially healthy? Addrly gives DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE profitable? The annual accounts of DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE for 2024 show a profit of € 119 664.

What is the equity of DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE? The equity of DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE was € 659 800 at the close of the 2024 financial year.

Who are the directors of DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE? The annual accounts of DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE record 1 mandate. The name, role and dates are visible with a free account.

Can DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE receive Peppol e-invoices? Yes. DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE is registered on the Peppol network and can receive structured electronic invoices.

What does DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE do? The main activity of DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE is: Human health activities.

Sources

How Addrly builds and refreshes this data